Table 2.
Type of VTE | LMWH | LMWH+GCS |
---|---|---|
Overall population (LMWH n=937, LMWH+GCS n=921) | ||
VTE within 90 days | 16 (1.7) | 13 (1.4) |
Type of VTE | ||
DVT with symptoms | 2 (12.5) | 1 (7.7) |
DVT without symptoms identified by duplex | 12 (75.0) | 11 (84.6) |
Imaging confirmed pulmonary embolism with symptoms | 2 (12.5) | 1 (7.7) |
Including exclusions after randomisation (LMWH n=943, LMWH+GCS n=932) | ||
VTE within 90 days | 16 (1.7) | 13 (1.4) |
Type of VTE | ||
DVT with symptoms | 2 (12.5) | 1 (7.7) |
DVT without symptoms identified by duplex | 12 (75.0) | 11 (84.6) |
Imaging confirmed pulmonary embolism with symptoms | 2 (12.5) | 1 (7.7) |
Including patients who had a duplex scan (LMWH n=810, LMWH+GCS n=767) | ||
VTE within 90 days | 16 (2.0) | 13 (1.7) |
Type of VTE | ||
DVT with symptoms | 2 (12.5) | 1 (7.7) |
DVT without symptoms identified by duplex | 12 (75.0) | 11 (84.6) |
Imaging confirmed pulmonary embolism with symptoms | 2 (12.5) | 1 (7.7) |
<65 years with high VTE risk (LMWH n=360, LMWH+GCS n=395) | ||
VTE within 90 days | 2 (0.6) | 1 (0.3) |
Type of VTE | ||
DVT with symptoms | 0 (0) | 1 (100.0) |
DVT without symptoms identified by duplex | 2 (100.0) | 0 |
DVT=deep vein thrombosis; GCS=graduated compression stockings; LMWH=low molecular weight heparin; VTE=venous thromboembolism.